54 related articles for article (PubMed ID: 11857074)
21. Molecular alterations in primary prostate cancer after androgen ablation therapy.
Best CJ; Gillespie JW; Yi Y; Chandramouli GV; Perlmutter MA; Gathright Y; Erickson HS; Georgevich L; Tangrea MA; Duray PH; González S; Velasco A; Linehan WM; Matusik RJ; Price DK; Figg WD; Emmert-Buck MR; Chuaqui RF
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6823-34. PubMed ID: 16203770
[TBL] [Abstract][Full Text] [Related]
22. Null mutation of the Lmo4 gene or a combined null mutation of the Lmo1/Lmo3 genes causes perinatal lethality, and Lmo4 controls neural tube development in mice.
Tse E; Smith AJ; Hunt S; Lavenir I; Forster A; Warren AJ; Grutz G; Foroni L; Carlton MB; Colledge WH; Boehm T; Rabbitts TH
Mol Cell Biol; 2004 Mar; 24(5):2063-73. PubMed ID: 14966285
[TBL] [Abstract][Full Text] [Related]
23. Structural basis for the recognition of ldb1 by the N-terminal LIM domains of LMO2 and LMO4.
Deane JE; Mackay JP; Kwan AH; Sum EY; Visvader JE; Matthews JM
EMBO J; 2003 May; 22(9):2224-33. PubMed ID: 12727888
[TBL] [Abstract][Full Text] [Related]
24. The hepatitis C virus internal ribosome entry site facilitates efficient protein synthesis in blood vessel endothelium during tumour angiogenesis.
Chung GT; Yamada Y; Pannell R; Forster A; Rabbitts TH
Nucleic Acids Res; 2003 Apr; 31(8):e46. PubMed ID: 12682381
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional control of fetal liver hematopoiesis: dominant negative effect of the overexpression of the LIM domain mutants of LMO2.
Terano T; Zhong Y; Toyokuni S; Hiai H; Yamada Y
Exp Hematol; 2005 Jun; 33(6):641-51. PubMed ID: 15911088
[TBL] [Abstract][Full Text] [Related]
26. Nestin-linked green fluorescent protein transgenic nude mouse for imaging human tumor angiogenesis.
Amoh Y; Yang M; Li L; Reynoso J; Bouvet M; Moossa AR; Katsuoka K; Hoffman RM
Cancer Res; 2005 Jun; 65(12):5352-7. PubMed ID: 15958583
[TBL] [Abstract][Full Text] [Related]
27. The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice.
Yamada Y; Pannell R; Forster A; Rabbitts TH
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):320-4. PubMed ID: 10618416
[TBL] [Abstract][Full Text] [Related]
28. Identification of the key LMO2-binding determinants on Ldb1.
Ryan DP; Sunde M; Kwan AH; Marianayagam NJ; Nancarrow AL; Vanden Hoven RN; Thompson LS; Baca M; Mackay JP; Visvader JE; Matthews JM
J Mol Biol; 2006 May; 359(1):66-75. PubMed ID: 16616188
[TBL] [Abstract][Full Text] [Related]
29. The Lim-only protein LMO2 acts as a positive regulator of erythroid differentiation.
Hansson A; Zetterblad J; van Duren C; Axelson H; Jönsson JI
Biochem Biophys Res Commun; 2007 Dec; 364(3):675-81. PubMed ID: 17964543
[TBL] [Abstract][Full Text] [Related]
30. The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target.
Yamada Y; Pannell R; Forster A; Rabbitts TH
Oncogene; 2002 Feb; 21(9):1309-15. PubMed ID: 11857074
[TBL] [Abstract][Full Text] [Related]
31. Angiogenesis--a new target for future therapy.
Pandya NM; Dhalla NS; Santani DD
Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
[TBL] [Abstract][Full Text] [Related]
32. The vascular network of tumours--what is it not for?
Sivridis E; Giatromanolaki A; Koukourakis MI
J Pathol; 2003 Oct; 201(2):173-80. PubMed ID: 14517833
[TBL] [Abstract][Full Text] [Related]
33. Modelling approaches for angiogenesis.
Taraboletti G; Giavazzi R
Eur J Cancer; 2004 Apr; 40(6):881-9. PubMed ID: 15120043
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
